Nicotinamide Riboside (NR)
nicotinamide riboside · NR · niagen
The other headline NAD⁺ precursor, marketed alongside NMN for cellular energy.
Il voto risponde a: What does the human evidence support for: NAD⁺ precursor?
Grado
Moderata
Il voto misura la qualità dell'evidenza, non è un consiglio ad assumere o acquistare.
- Classe
- Cellular metabolism
- Uso principale
- NAD⁺ precursor
- Forza evidenza
- medium
- Ultima revisione
- 2026-07-01
In sintesi
Like NMN, it reliably raises blood NAD⁺ in humans — and, like NMN, that hasn't yet translated into proven clinical benefit. Well tolerated, biologically real, clinically unproven.
Cosa dice l'evidenza
Studi chiave
- [1]
Nicotinamide riboside raises NAD⁺ in humans (RCTs) · RCT
Reliable rise in blood NAD⁺; safe short-term.
Apri su PubMed ↗ - [2]
NR and clinical/functional outcomes · review
Surrogate markers move; hard endpoints not established.
Apri su PubMed ↗ - [3]
NAD⁺ precursors in aging (review) · review
Places NR and NMN in the same evidence bracket.
Apri su PubMed ↗
Meccanismo
Sicurezza
Contesto dosaggio
Esempi di applicazione
- Taken as a daily morning capsule, much like NMN.
- Often chosen over NMN on price, since the evidence is similar.
- Sometimes paired with TMG on theory, though that pairing isn't proven.
Nota dal campo
NR and NMN are sold as rivals; in the evidence they're near-twins. We grade both B and make the same point: the NAD⁺ goes up, the proof that it makes you healthier isn't there yet.

